The availability and use of medicines to control infestations of sea lice on Atlantic salmon, Salmo salar L., farms in Scotland has changed considerably in the last decade (Lees, Gettinby & Revie 2008b) . Whereas hydrogen peroxide and organophosphate compounds were used widely throughout the 1990s and in the early 2000s, only two therapeutants have remained in common use since 2005: topical cypermethrin (Excis Ò ; Novartis Animal Health, Camberley, UK) and an oral formulation of emamectin benzoate (SLICE Ò ; Schering Plough Animal Health, Uxbridge, UK).
Although Excis Ò and SLICE Ò are effective against the two major species of sea lice that parasitize Atlantic salmon on Scottish farms, i.e. Lepeophtheirus salmonis (Krøyer, 1837) and Caligus elongatus (Nordmann, 1832) , reliance on such a limited range of therapeutants has raised concerns that resistance in lice will become an increasing problem unless new medicines become available and/or existing treatments are carefully managed (Denholm, Devine, Horsberg, Sevatdal, Fallang, Nolan & Powell 2002) . These concerns are felt not only in Scotland, but also in other salmon produc ing countries where the choice of sea lice therapeu tants is limited (Westcott, Hammell & Burka 2004) . Indeed, in recent years, there have been anecdotal reports of reduced sensitivity of sea lice to emamectin benzoate, particularly amongst Caligus rogercresseyi Boxshall & Bravo, 2000, populations in Chile (S. Bravo, personal communication) .
Since gaining UK Marketing Authorization in 2000 the use of SLICE Ò has risen dramatically on Scottish salmon farms not least because, as an in feed medicine, it offers several advantages in terms of application over topical treatments. However, the key benefit of SLICE Ò is that it can provide sustained periods of louse clearance (Stone, Sutherland, Sommerville Ò was the only sea lice medicine administered and where all pens began treatment on the same day were analysed (n = 185). As described in the previous study (Lees et al. 2008a) , these treatment episodes were screened to establish whether sufficient lice count data were available in the weeks prior to and following treatment to allow further analysis (n = 108). In addition, 26 treatments that were administered before guideline treatment trigger levels had been reached (i.e. mean abundance of L. salmonis adult females < 0.5 February June, or ‡ 1.0 between July and January) were screened out. This resulted in a final data set of 82 treatment episodes administered across 40 farms.
Using the available lice count data, post treat ment L. salmonis abundance in the 12 weeks (83 days) following treatment intervention was examined as mean mobile lice per fish; and as a percentage of pretreatment abundance based on matched pre and post treatment lice counts (mean post treatment abundance/mean pretreatment abundance · 100). Treatments were then classified as ÔeffectiveÕ (n = 63) or ÔineffectiveÕ (n = 19), with effective treatments defined as those where the mean abundance of mobile L. salmonis fell below 40% of pretreatment levels in at least one of the 12 weeks following treatment. A summary of all treatments included in the analysis is presented in Table 1 .
In the previous study (Lees et al. 2008a) , all treatment episodes were analysed regardless of whether they were classified as effective or not. However, as treatment episodes may be ineffective for a number of reasons unrelated to reduced sensitivity or resistance amongst lice populations, it was important to further examine underlying trends amongst only those treatment episodes deemed to be effective (n = 63). Figure 1a shows that, despite very different pretreatment lice burdens ranging from 18 lice per fish in 2003 to five in 2005, mean mobile abundance fell below 3.5 within 27 days of treatment initiation in all years. Mean abundance continued to fall to below 1.3 lice by day 55.
The efficacy profiles (Fig. 1b) show that in 2002 and 2003 mean louse abundance fell to 10% of pretreatment levels within 20 days of treatment intervention and below 3% by day 27. Treatments applied in 2004 were also highly effective, with mean abundance falling to 6% of pretreatment levels by day 27. In 2005, lice levels fell to 23% of pretreatment abundance within 27 days, continued to fall to 15% by day 55, recovering gradually thereafter. In 2006, abundance as a proportion of pretreatment levels fell to 19% by day 27 and to 9% between days 28 and 34, however after this point it began to rise. A general linear model was developed for the 63 effective treatment episodes. In addition to year of treatment, the model examined the effect of several other factors on post treatment mobile L. salmonis abundance and included pretreatment lice loads as a co variate (Table 2) . To improve normality and equalize variances, data were logarithmically trans formed [ln(x + 1)] prior to analysis. Least squares means and their 95% confidence intervals (CI) are reported untransformed.
All factors were found to be significant and a significant interaction between region and days after treatment was observed (Table 2 (Table 1) , a logistic regression model was developed to determine whether any factors were associated with ineffective treatment episodes (Table 3 ). All treatments given in 2002 were effective, therefore episodes administered in this year could not be included in the logistic model, leaving a total of 19 ineffective and 54 effective treatment episodes for analysis. Table 3 shows the final logistic regression model that was developed and includes the factors that were found to be significant within the multivar iable analysis (P £ 0.05). The analysis shows that treatments given in 2006 were 11 times (P = 0.02, CI 1.42 90.17) more likely to be ineffective than those given in 2003 and that winter treatments were also around 11 times (P = 0.01, CI 1.60 71.73) more likely to fail than those given in the spring. Pretreatment mobile lice abundance was included in the model as a forced co variate, however it was not found to be significant, indicating that lice levels prior to treatment intervention were not a factor in determining the success of a treatment. In addition, it was found that production year, geographical region, and whether the treatment was part of a loch wide intervention had no significant association with ineffective treatment episodes. Sensitivity analysis was carried out to assess the impact of revising the effective treatment episode criteria up or down from 40% of pretreat ment levels. Two additional logistic regression analyses were performed. In the first analysis, the cut off point for effective treatment episodes was lowered to 20% of pretreatment lice levels; in the second, the cut off point was increased to 50%. In both analyses, year (2006) and season (winter) were once again found to be the only statistically significant factors.
It is acknowledged that the efficacy of in feed sea lice treatment episodes may be influenced by a number of factors relating to fish appetite, sub therapeutic dosing and concurrent disease. Further more, it should be noted that the apparent reduction in treatment efficacy reported herein occurred within a 5 year period when lice abundance was found to be comparatively low (Lees et al. 2008b) . Nevertheless, it is critical that the efficacy of this widely used sea lice medicine continues to be monitored closely and that fish health managers remain vigilant in reporting any apparent treatment failures. 
